60.69

2.04% -1.385

Boston Scientific Corp (BSX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$62.07

Aprire:

$61.21

Volume 24 ore:

7.09M

Relative Volume:

0.42

Capitalizzazione di mercato:

$90.31B

Reddito:

$20.62B

Utile/perdita netta:

$3.56B

Rapporto P/E:

25.45

EPS:

2.3847

Flusso di cassa netto:

$3.66B

1 W Prestazione:

-0.30%

1M Prestazione:

-12.09%

6M Prestazione:

-40.64%

1 anno Prestazione:

-40.33%

Intervallo 1D:

$60.56

$61.73

Intervallo di 1 settimana:

$59.38

$66.88

Portata 52W:

$59.38

$109.50

Boston Scientific Corp Stock (BSX) Company Profile

Nome

Boston Scientific Corp

Settore

Healthcare (1117)

Industria

Medical Devices (142)

Telefono

508-683-4000

Indirizzo

300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA

Dipendente

59,000

Cinguettio

@bostonsci

Prossima data di guadagno

2026-04-22

Ultimi documenti SEC

BSX's Discussions on Twitter

Compare BSX vs ABT, SYK, MDT, EW

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BSX Boston Scientific Corp	60.77	92.25B	20.62B	3.56B	3.66B	2.3847
ABT Abbott Laboratories	92.56	158.35B	45.13B	6.28B	7.40B	3.5895
SYK Stryker Corp	327.88	125.43B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	82.90	106.97B	35.48B	4.64B	5.41B	3.582
EW Edwards Lifesciences Corp	84.54	48.52B	6.30B	1.07B	1.34B	1.8406

Boston Scientific Corp Stock (BSX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-03-30	Downgrade	Raymond James	Strong Buy → Outperform
2025-10-03	Downgrade	Erste Group	Buy → Hold
2025-09-08	Aggiornamento	Oppenheimer	Perform → Outperform
2025-06-16	Iniziato	Leerink Partners	Outperform
2025-04-16	Aggiornamento	Needham	Hold → Buy
2025-01-10	Aggiornamento	Deutsche Bank	Hold → Buy
2024-10-18	Downgrade	Needham	Buy → Hold
2024-05-30	Iniziato	Goldman	Buy
2024-02-01	Aggiornamento	Mizuho	Neutral → Buy
2023-07-19	Iniziato	Robert W. Baird	Outperform
2023-06-30	Iniziato	CL King	Buy
2023-05-30	Ripresa	Morgan Stanley	Overweight
2023-03-29	Iniziato	UBS	Buy
2022-12-22	Iniziato	Mizuho	Neutral
2022-12-20	Ripresa	Citigroup	Buy
2022-10-18	Iniziato	Barclays	Overweight
2022-10-12	Iniziato	Jefferies	Buy
2022-07-06	Iniziato	Wolfe Research	Outperform
2022-05-27	Aggiornamento	Needham	Hold → Buy
2022-04-13	Ripresa	Truist	Buy
2022-03-02	Ripresa	BofA Securities	Buy
2021-12-10	Iniziato	RBC Capital Mkts	Outperform
2021-05-26	Downgrade	Needham	Buy → Hold
2021-05-25	Iniziato	Barclays	Overweight
2021-04-15	Iniziato	Atlantic Equities	Overweight
2020-09-17	Iniziato	Truist	Buy
2020-09-11	Iniziato	Wolfe Research	Peer Perform
2020-04-22	Downgrade	SVB Leerink	Outperform → Mkt Perform
2020-04-01	Aggiornamento	Goldman	Neutral → Buy
2020-03-05	Iniziato	Citigroup	Buy
2020-02-13	Iniziato	Goldman	Neutral
2020-02-06	Ripresa	BTIG Research	Buy
2019-12-30	Reiterato	Cowen	Outperform
2019-12-19	Downgrade	Needham	Strong Buy → Buy
2019-09-05	Ripresa	JP Morgan	Overweight
2019-09-03	Ripresa	Barclays	Overweight
2019-05-13	Aggiornamento	Evercore ISI	In-line → Outperform
2018-11-28	Iniziato	UBS	Buy
2018-10-16	Iniziato	Barclays	Overweight
2018-10-02	Reiterato	Morgan Stanley	Overweight
2018-09-07	Reiterato	Needham	Strong Buy
2018-09-04	Aggiornamento	Jefferies	Hold → Buy
2018-07-06	Reiterato	Needham	Strong Buy
2018-06-27	Iniziato	Bernstein	Outperform
2018-04-26	Reiterato	Needham	Strong Buy

Mostra tutto

Boston Scientific Corp Borsa (BSX) Ultime notizie

Apr 26, 2026

BSX DEADLINE: ROSEN, LEADING TRIAL COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - GlobeNewswire Inc.

Apr 26, 2026

Boston Scientific Corp at TD Cowen Healthcare Conference Transcript - GuruFocus

Apr 26, 2026

Boston Scientific (BSX) Unveils Promising Results for Heart Tech - GuruFocus

Apr 26, 2026

One Boston Scientific heart device beat drug therapy in new trial data - Stock Titan

Apr 26, 2026

Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.

Apr 26, 2026

Apr 25, 2026

Boston Scientific Corp. Opens with 4.84% Gain, Outperforming S&P 500's 1.05% Increase - Markets Mojo

Apr 25, 2026

BSX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com

Apr 25, 2026

symbol__ Stock Quote Price and Forecast - CNN

Apr 25, 2026

Calamos Wealth Management LLC Cuts Stake in Boston Scientific Corporation $BSX - MarketBeat

Apr 25, 2026

Boston Scientific Corporation $BSX Shares Sold by Calamos Advisors LLC - MarketBeat

Apr 25, 2026

Boston Scientific Corp Investor Event at the Scientific Session of the American College of Cardiology Transcript - GuruFocus

Apr 25, 2026

Apr 24, 2026

BSX DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class ActionBSX - TMX Newsfile

Apr 24, 2026

A Look at Boston Scientific Corp (BSX) After 5.5% Decline -- GF Value $104.55 vs Price $62.07 - GuruFocus

Apr 24, 2026